- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human monoclonal antibody to insulin receptor
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human monoclonal antibody to insulin receptor
| EU orphan designation number: | EU/3/16/1702
|
| Active ingredient: | Recombinant human monoclonal antibody to insulin receptor |
| Indication: | Treatment of congenital hyperinsulinism |
| Sponsor: | XOMA UK Limited
c/o Arnold & Porter (UK) LLP, Tower 42, 25 Old Broad Street, London EC2N 1HQ, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 18/07/2016 | Orphan designation | EMA/OD/040/16 | (2016)4688 of 14/07/2016 |
CONTACT
EU links
Directorate General Health & Consumers